4

Message to Our Shareholders Regarding the Licensing of Cevidoplenib

Jun 2, 2026

3

Oscotec Shareholder Letter_2026 Annual General Meeting

Mar 19, 2026

2

To the Shareholders of Oscotec

May 19, 2025

1

Oscotec The 27th Annual Meeting of Shareholders Reference Materials

Mar 13, 2025